from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3111/moaC1

LFCtreatmentdescriptionclass of inhibitor

0.578

Amikacinug/mL Amikacintranslation

-0.604

Cap5-10ug/mL Capreomycintranslation

-0.878

Rox10-50 ug/mL Roxithromycintranslation

-0.260

SM2-5 ug/mL Streptomycintranslation

-0.340

Tet5-10 ug/mL Tetracyclinetranslation

1.349

Rif0.2-5ug/mL Rifampicintranscription

2.293

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.654

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.352

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.032

CPZ10-50 ug/mL Chlorpromazinerespiration

0.279

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.217

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.395

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.775

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.858

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.470

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.370

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.004

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.261

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.665

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.173

KCN5-20 ug/mL Potassium cyaniderespiration

-0.593

NaN30.2-2 mM Sodium aziderespiration

-1.860

Nigericin50 uM Nigericinrespiration

1.115

TRC10-150 ug/mL Triclosanrespiration

1.127

TRZ10-25 ug/mL Thioridazinerespiration

-1.153

Valinomycin0.5-10 uM Valinomycinrespiration

-0.847

ZnSO42 mM ZnSO4respiration

-0.143

menadione6-10 ug/mL Menadionerespiration

0.095

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.059

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.384

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.040

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.827

NRP_1Non-replicating persistence stage 1dosRassociated

-0.319

Amp0.2mg/mL AmpicillincellWall

-0.420

Cephalexin20-100 ug/mL CephalexincellWall

-0.159

Cerulenin0.32-5 ug/mL CerulenincellWall

0.138

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.359

EMB10-20 ug/mL EthambutolcellWall

-0.621

Eta12-40 ug/mL EthionamidecellWall

-0.934

INH0.2-0.4 ug/mL IsoniazidcellWall

0.272

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.492

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.190

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.089

BZA0.12 mg/mL BenzamidearomaticAmides

-0.028

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.644

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.627

H2O24 mM hydrogen peroxideDNAdamaging

0.298

Levo10 ug/mL LevofloxacinDNAdamaging

-0.179

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.174

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.376

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.360

UVUV-irradiationDNAdamaging

0.709

ARP41-4 ug/mL Antitubercular compound ARP4?

0.755

Antimycin12.5-50 ug/mL Antimycin A?

-1.113

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.387

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.153

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.167

PA8240.2-2 ug/mL PA-824?

0.029

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.062

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.594

Verapamil50 uM Verapamil?

-0.751

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.118

methoxatin10-20 ug/mL Methoxatin?